glycopyrrolate has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barjaktarevic, I; Hanania, NA; Mahler, DA; Make, B; Mintz, M; Skolnik, N; Yawn, B; Zeyzus-Johns, B | 1 |
| Garg, H | 1 |
1 review(s) available for glycopyrrolate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Bronchodilator Agents; COVID-19; Drug Therapy, Combination; Formoterol Fumarate; Glycopyrrolate; Humans; Pulmonary Disease, Chronic Obstructive | 2023 |
1 other study(ies) available for glycopyrrolate and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Can glycopyrrolate come to the airway rescue in Covid-19 patients?
Topics: Atropine; Betacoronavirus; Coronavirus Infections; COVID-19; Glycopyrrolate; Humans; Intubation, Intratracheal; Pandemics; Pneumonia, Viral; Premedication; SARS-CoV-2 | 2020 |